GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LeMaitre Vascular Inc (NAS:LMAT) » Definitions » Price-to-Free-Cash-Flow

LeMaitre Vascular (LeMaitre Vascular) Price-to-Free-Cash-Flow

: 48.18 (As of Today)
View and export this data going back to 2006. Start your Free Trial

As of today (2024-04-19), LeMaitre Vascular's share price is $63.26. LeMaitre Vascular's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.31. Hence, LeMaitre Vascular's Price-to-Free-Cash-Flow Ratio for today is 48.18.

The historical rank and industry rank for LeMaitre Vascular's Price-to-Free-Cash-Flow or its related term are showing as below:

LMAT' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 21.92   Med: 40.7   Max: 101.01
Current: 48.19

During the past 13 years, LeMaitre Vascular's highest Price-to-Free-Cash-Flow Ratio was 101.01. The lowest was 21.92. And the median was 40.70.

LMAT's Price-to-Free-Cash-Flow is ranked worse than
69.73% of 337 companies
in the Medical Devices & Instruments industry
Industry Median: 31.21 vs LMAT: 48.19

LeMaitre Vascular's Free Cash Flow per Share for the three months ended in Dec. 2023 was $0.42. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $1.31.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of LeMaitre Vascular was 31.60% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -5.40% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 13.10% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 20.20% per year.

During the past 13 years, LeMaitre Vascular's highest 3-Year average Free Cash Flow per Share Growth Rate was 66.60% per year. The lowest was -17.30% per year. And the median was 23.70% per year.


LeMaitre Vascular Price-to-Free-Cash-Flow Historical Data

The historical data trend for LeMaitre Vascular's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LeMaitre Vascular Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70.08 26.06 35.70 46.07 43.16

LeMaitre Vascular Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.07 62.92 79.25 53.52 43.16

Competitive Comparison

For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LeMaitre Vascular Price-to-Free-Cash-Flow Distribution

For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where LeMaitre Vascular's Price-to-Free-Cash-Flow falls into.



LeMaitre Vascular Price-to-Free-Cash-Flow Calculation

LeMaitre Vascular's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=63.26/1.313
=48.18

LeMaitre Vascular's Share Price of today is $63.26.
LeMaitre Vascular's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.31.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

LeMaitre Vascular  (NAS:LMAT) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


LeMaitre Vascular Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of LeMaitre Vascular's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


LeMaitre Vascular (LeMaitre Vascular) Business Description

Traded in Other Exchanges
Address
63 Second Avenue, Burlington, MA, USA, 01803
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are primarily used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes the largest proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.
Executives
George W Lemaitre director, 10 percent owner, officer: Chairman, President and CEO 342 BUNKER HILL STREET, #2B, CHARLESTOWN MA 02129
Bridget A Ross director C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
John A Roush director C/O GSI GROUP INC., 125 MIDDLESEX TURNPIKE, BEDFORD MA 01730-1409
Lawrence J Jasinski director SOTEIRA INC., 14 TECH CIRCLE, NATICK MA 01760
David B Roberts director, officer: CFO and Director 55 BRADFORD STREET, NEEDHAM MA 02492
Trent G Kamke officer: Senior V. P., Operations 61 WILLOWDEAN AVENUE, WEST ROXBURY MA 02132
Martha Shadan director 9201 W BROADWAY AVE, #650, MINNEAPOLIS MN 55445
Pellegrino Joseph P Jr officer: Executive V.P. Finance 68 BEACON STREET, BOSTON MA 02108
Michael H Thomas director P.O. BOX 2207, NOKOMIS FL 34274-2207
Peter R Gebauer officer: President, International OP AM WALDFELD 17, BAD SODEN 2M 65812
Michael T Wijas officer: VP of Sales, The Americas C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON MA 01803
Lemaitre Cornelia W director, officer: V.P., Human Resources,Director 8 SUNSET ROCK ROAD, ANDOVER MA 01810
Russell D Hays director C/O BIOSOURCE INTERNATIONAL INC, 542 FLYNN RD, CAMARILLO CA 93012
Robert V Linden officer: VP, North American Sales 236 WOODEN BRIDGE ROAD, HOLLAND PA 18966
Thorndike William N Jr director HOUSATONIC PARTNERS, 800 BOYLSTON STREET, SUITE 2220, BOSTON MA 02199

LeMaitre Vascular (LeMaitre Vascular) Headlines